Paul Schimmel, Director at aTYR PHARMA INC (ATYR), bought 2,000,000 shares at $0.90 ($1.8M) on 2025-10-08, disclosed to the SEC on 2025-10-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.90 | 682,001 | $614K | 33.6% |
| 2 | $0.90 | 682,001 | $614K | 33.6% |
| 3 | $0.94 | 317,999 | $299K | 16.4% |
| 4 | $0.94 | 317,999 | $299K | 16.4% |
| Total | $0.91 avg | 2,000,000 | $1.8M | 100% |
| Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |
| LIFE | BUY | 2021-05-20 | $199K | — | Filing → |